Career history of Joel A. Fernandes
Former positions of Joel A. Fernandes
| Companies | Position | Start | End |
|---|---|---|---|
| INNOVIVA, INC. | Corporate Officer/Principal | 2004-12-31 | 2006-02-28 |
| KLA CORPORATION | Corporate Officer/Principal | 2002-07-31 | 2004-12-31 |
| ALZA CORPORATION | Corporate Officer/Principal | 1998-12-31 | 2001-12-31 |
| INNOVIVA, INC. | Corporate Officer/Principal | - | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Comptroller/Controller/Auditor | 2006-03-31 | - |
| Director of Finance/CFO | 2006-03-31 | - | |
| Investor Relations Contact | 2006-03-31 | 2013-12-01 | |
| Public Communications Contact | 2006-03-31 | 2013-12-01 |
Training of Joel A. Fernandes
| Manchester College | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 4 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| KLA CORPORATION | Electronic Technology |
| Private companies | 2 |
|---|---|
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Stock Market
- Insiders
- Joel A. Fernandes
- Experience
